Magnetic resonance imaging (MRI) is mandatory to identify the epileptogenic zone in refractory temporal lobe epilepsy (TLE). The correct identification of lesions is essential to obtain good post-surgery seizure control. Low grade tumours (LGT) and focal cortical dysplasia (FCD) are common findings in symptomatic TLE, and frequently coexist. The aim of this study was to identify the MRI characteristics in the diagnosis of FCD associated with LGT. We analyzed 24 subjects with TLE who underwent tailored surgery. They all had LGTs. Two expert neuroradiologists analyzed the imaging data and compared them with histological results, hypothesizing the causes of diagnostic errors in the identification of FCD. We selected three exemplary cases to report the most important causes of errors. In the diagnosis of FCD we reported false positives and false negatives due to different causes. An incomplete MRI protocol, the large dimensions of the tumour, infiltration and related oedema were the most important factors limiting MRI accuracy. MRI can be limited by an incomplete protocol. In addition, the presence of an LGT may limit the neuroradiological diagnosis of FCD in the temporal lobe. Advanced MRI techniques could help reveal subtle lesions that eluded a previous imaging inspection.
ColomboNCitterioAMunariC. 2001 Epilessia. In: Dal PozzoG ed. Compendio di Risonanza Magnetica — Cranio e rachide. Turin: Utet; 2001. p. 657–704.
2.
LudersDMarshRde TriboletN. Low grade glioma in intractable epilepsy: lesionectomy versus epilepsy surgery. Acta Neurochir. 2006; Suppl 68: 70–74.
3.
AronicaELeenstraSvan VeelenCW. Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow up of seizure outcome after surgery. Epilepsy Res.2001; 43: 179–191.
4.
BlumkeIWieslerOD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002; 61: 575–584.
5.
CataltepeOTuranliGYalnizogluD. Surgical management of temporal lobe tumor-related epilepsy in children. J Neurosurgery. 2005;102 (Suppl 3): 280–287.
6.
MinkinKKleinOManciniJ. Surgical strategies and seizure control in pediatric patients with dysembrioplastic neuroepithelial tumors: a single-institution experience. J Neurosurg Pediatrics. 2008; 1: 206–210.
7.
LuykenCBlumckeIFimmersR. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003; 44: 822–830.
8.
GiulioniMGalassiEZucchelliM. Seizure out come of lesionectomy in glioneuronal tumors associated with epilepsy in children. J Neurosurg Pediatrics. 2005; 102: 288–293.
9.
GiulioniMGardellaERubboliG. Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J Clin Neurosci. 2006; 13: 529–535.
10.
GiulioniMRubboliGMarucciG. Seizure out come of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection. J Neurosurg. 2009; 111: 1275–1282.
11.
PraysonRAFongJNajmI. Coexistent pathology in chronic epilepsy patients with neoplasms. Mod Pathol. 2010; 23: 1097–1103.
12.
MathiesonG. Pathologic aspects of epilepsy with special reference to the surgical pathology of focal cerebral seizures. In: PurpuraDPenryJKWalterRD eds. Advances in Neurology. New York: Raven Press; 1995. p. 107–138.
13.
BrutonCJ. The neuropathology of temporal lobe epilepsy. Oxford: Oxford University Press; 1988.
14.
PlateKHWieserHGYasargilMG. Neuropathological findings in 224 patients with temporal lobe epilepsy. Acta Neuropathol. 1993; 86: 433–438.
15.
WolfHKCamposMGZentnerJ. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol. 1993; 52: 499–506.
MasuiKSuzukiSOHashiguchiK. Focal cortical dysplasia coexisting with diffuse astrocytoma in childhood: a case report and reappraisal of the glial component in archival FCD cases. Neuropathology. 2011; 31: 433–439.
18.
ModhaAVassilyadiMKeeneD. Temporal lobe focal cortical dysplasia: MRI imaging using FLAIR shows lesions coexistent with neoplasia. Childs Nerv Syst. 2000; 16: 350–379.
19.
Lockwood-EstrinGThomMFockeNK. Correlating 3T MRI and histopathology in patients undergoing epilepsy surgery. J Neurosci Methods. 2012; 205: 182–189.
MorrisHHMatkovicZEstesML. Ganglioglioma and intractable epilepsy: clinical and neurophysiologic features and predictors of outcome after surgery. Epilepsia. 1998; 39: 307–313.
22.
HammondRRDuggalNWoulfeJM. Malignant transformation of a dysembryoplastic neuroepithelial tumor. Case report. J Neurosurg. 2000; 92: 722–725.
23.
GiulioniMMartinoniMRubboliG. Temporomesial extraventricular neurocytoma and cortical dysplasia in focal temporal lobe epilepsy. J Clin Neurosci. 2010; 18: 147–148.
24.
BarkovichAJRaybaudCA. Malformation of cortical development. Neuroimaging Clin N Am.2004; 14: 401–423.
25.
PalminiANajmIAvanziniG. Terminology and classification of the cortical dysplasias. Neurology. 2004;62 (6Suppl 3): S2–S8.
26.
LombardiDMarschRDe TriboletN. Low grade glioma in intractable epilepsy: lesionectomy versus epilepsy surgery. Acta Neurochir. 1997; Suppl 68: 70–74.
AdamsbaumCROCohenPADelalandeO. Focal cortical dysplasia and hemimegaencephaly: histological and neuroimaging correlations. Pediatr Radiol. 1998; 28: 583–590.
29.
BastosAComeauRAndermannF. Diagnosis of subtle focal dysplastic lesions: curvilinear reformatting from tree-dimensional magnetic resonance imaging. Ann Neurol. 1999; 46: 88–94.
30.
LeeBSchmidtRHatfieldG. MRI of focal cortical dysplasia. Neuroradiology. 1998; 40: 675–683.
31.
BlumckeIThomMAronicaE. The clinicopathologic spectrum of cortical focal dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Method Commission. Epilepsia. 2011; 52: 158–174.
32.
ColomboNTassiLDeleoF. Focal cortical dysplasia type IIa and IIb: MRI aspects in 118 cases proven by histopathology. Neuroradiology. 2012; 54: 1065–1077.
33.
BarkovichAJKuznieckyRIJacksonGD. A development and genetic classification for malformations of cortical development. Neurology. 2005; 65: 1873–1887.
34.
ColomboNSalamonNRaybaudC. Imaging of malformations of cortical development. Epileptic Disord. 2009; 11: 194–205.
35.
LernerJTSalamonNHauptmanJS. Assessment and surgical outcomes for mild type I and severe Type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia. 2009; 50: 1310–1335.
BernasconiABernasconiNBernhardtBC. Advances in MRI for cryptogenic epilepsies. Nature reviews, Neurology. 2011; 7: 99–108.
38.
MulebnerACorasRKobowK. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol. 2012; 123: 259–272.
39.
ChassouxFLandrèEMellerioC. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia. 2012; 53: 349–358.
40.
BessonPAndermannFDubeauF. Small focal cortical dysplasia lesions are located at the bottom of a deep sulcus. Brain. 2008; 131: 3246–3255.
41.
HanXJovicicJSalatD. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 2006; 32: 180–194.
42.
KassubekJHuppertzHJSpreerJ. Detection and localization of focal cortical dysplasia by voxel-based 3-D MRI analysis. Epilepsia. 2002; 43: 596–602.
43.
ColliotOAntelSBNaessensVB. In vivo profiling of focal cortical dysplasia on high-resolution MRI with computational models. Epilepsia. 2006; 47: 134–142.
44.
HaidarHSoulJS. Measurements of cortical thickness in 3D brain imaging data: validation of the Laplacian method. J Neuroimaging. 2006; 16: 146–153.
45.
MerschemkeMMitchellTNFreeSL. Quantitative MRI detects abnormalities in relatives of patients with epilepsy and malformations of cortical development. Neuroimage. 2003; 18: 642–649.
46.
WilkeMKassubekJZiyehS. Automated detection of gray matter malformations sign optimized voxel-based morphometry: a systematic approach. Neuroimage. 2003; 20: 330–343.
47.
BonilhaLMontenegroMARordenC. Voxel-based morphometry reveals excess gray matter concentration in patients with focal cortical dysplasia. Epilepsia. 2006; 47: 908–915.
48.
ColliotOBernasconiNKhaliliN. Individual voxel based analysis of gray matter in focal cortical dysplasia. Neuroimage. 2006; 29: 162–171.
49.
BruggermanJMWilkeMSomSS. Voxel-based morphometry in the detection of dysplasia and neoplasia in childhood epilepsy: combined gray/white matter analysis augments detection. Epilepsy Res.2007; 77: 93–101.
50.
BruggermanJMWilkeMSomSS. Voxel based morphometry in the detection of dysplasia and neoplasia in childhood epilepsy: limitations of gray matter analysis. J Clin Neurosci. 2009; 16: 780–785.
51.
BronenRASpencerDDFulbrightRK. Cerebrospinal fluid cleft with cortical dimple: MR imaging marker for focal cortical dysgenesis. Radiology. 2000; 214: 657–663.
52.
Rugg-GunnFJErikssonSHSymmsMR. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain. 2001; 124: 627–636.
53.
GuyeMRanjevaJPBartolomeiF. What is the significance of interictal water diffusion changes in the frontal lobe epilepsies?Neuroimage. 2007; 35: 28–37.
54.
ThivardLAdamCHasbounD. Interictal diffusion MRI in partial epilepsies explored with intracerebral electrodes. Brain. 2006; 129: 375–385.
55.
Le BihanDManginJFPouponC. Diffusion Tensor Imaging: concepts and applications. J Magn Reson Imaging. 2001; 13: 534–546.
